ARCHIVES

AACI Leaders Regret “Unfortunate Rhetoric,” Pledge Support To Broder

This article is from The Cancer Letter archive.

Vol. 15 No. 32 | August 11, 1989

Download PDF Visit The Full Archive

Related Articles

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Funding Opportunities

January 10, 2003

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

A History of NCCN

January 13, 2012

Support For Translational Researchers Urgently Needed, ASCO President Says

May 22, 1998